SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2zfu'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MZ9_A_VDYA1002_4 (CARTILAGE OLIGOMERIC MATRIX PROTEIN)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	4 / 5	VAL A 342 CYH A 332 ALA A 323 CYH A 320	None	1.12A	1mz9D-2zfuA: undetectable	1mz9D-2zfuA: 11.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1X1A_A_SAMA4264_0 (CRTF-RELATED PROTEIN)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 12	GLY A 316 GLY A 318 LEU A 335 ASP A 346 CYH A 363	SAH A 900 (-3.5A) SAH A 900 ( 3.7A) SAH A 900 (-4.2A) SAH A 900 (-3.6A) SAH A 900 (-3.4A)	0.93A	1x1aA-2zfuA: 12.9	1x1aA-2zfuA: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AVV_E_MK1E902_4 (POL POLYPROTEIN)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	3 / 3	ARG A 298 VAL A 415 GLY A 386	None	0.66A	2avvE-2zfuA: undetectable	2avvE-2zfuA: 19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2C2B_E_SAME500_0 (THREONINE SYNTHASE 1, CHLOROPLASTIC)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 11	SER A 263 GLY A 261 SER A 260 LEU A 366 ASP A 346	SAH A 900 (-4.2A) None None None SAH A 900 (-3.6A)	0.99A	2c2bE-2zfuA: 0.7 2c2bF-2zfuA: 0.5	2c2bE-2zfuA: 18.84 2c2bF-2zfuA: 18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y69_C_CHDC1265_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	4 / 5	PHE A 374 PHE A 362 LEU A 388 PHE A 412	SAH A 900 (-4.3A) None None None	1.36A	2y69C-2zfuA: undetectable 2y69J-2zfuA: undetectable	2y69C-2zfuA: 19.85 2y69J-2zfuA: 17.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	4 / 5	PHE A 374 PHE A 362 LEU A 388 PHE A 412	SAH A 900 (-4.3A) None None None	1.36A	3abmP-2zfuA: undetectable 3abmW-2zfuA: undetectable	3abmP-2zfuA: 19.85 3abmW-2zfuA: 16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	4 / 5	PHE A 374 PHE A 362 LEU A 388 PHE A 412	SAH A 900 (-4.3A) None None None	1.33A	3ag3C-2zfuA: undetectable 3ag3J-2zfuA: undetectable	3ag3C-2zfuA: 19.85 3ag3J-2zfuA: 16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G2O_B_SAMB600_0 (PCZA361.24)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 12	GLY A 318 LEU A 322 LEU A 335 ASP A 346 MET A 347	SAH A 900 ( 3.7A) None SAH A 900 (-4.2A) SAH A 900 (-3.6A) SAH A 900 (-3.6A)	0.75A	3g2oB-2zfuA: 12.4	3g2oB-2zfuA: 23.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G2O_B_SAMB600_0 (PCZA361.24)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 12	GLY A 318 LEU A 335 ASP A 346 MET A 347 SER A 365	SAH A 900 ( 3.7A) SAH A 900 (-4.2A) SAH A 900 (-3.6A) SAH A 900 (-3.6A) SAH A 900 (-4.7A)	0.95A	3g2oB-2zfuA: 12.4	3g2oB-2zfuA: 23.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3I5U_B_SAMB401_1 (O-METHYLTRANSFERASE)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	3 / 3	ASP A 334 PHE A 270 SER A 263	SAH A 900 (-2.7A) None SAH A 900 (-4.2A)	0.79A	3i5uB-2zfuA: 11.6	3i5uB-2zfuA: 22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OU7_C_SAMC300_1 (SAM-DEPENDENT METHYLTRANSFERASE)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	3 / 3	GLY A 318 ASP A 334 ASP A 346	SAH A 900 ( 3.7A) SAH A 900 (-2.7A) SAH A 900 (-3.6A)	0.36A	3ou7C-2zfuA: 10.2	3ou7C-2zfuA: 24.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PFG_A_SAMA264_0 (N-METHYLTRANSFERASE)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 12	TYR A 280 GLY A 318 LEU A 335 ASP A 346 MET A 347	None SAH A 900 ( 3.7A) SAH A 900 (-4.2A) SAH A 900 (-3.6A) SAH A 900 (-3.6A)	0.98A	3pfgA-2zfuA: 11.6	3pfgA-2zfuA: 23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R9V_B_DXCB1_0 (INVASIN IPAD)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	4 / 7	ILE A 326 LEU A 322 VAL A 381 SER A 356	None	0.97A	3r9vA-2zfuA: undetectable 3r9vB-2zfuA: undetectable	3r9vA-2zfuA: 22.66 3r9vB-2zfuA: 22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SOA_A_DB8A445_1 (CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE II SUBUNIT ALPHA WITH A BETA 7 LINKER)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	4 / 6	LEU A 352 VAL A 350 PHE A 315 VAL A 357	None	1.12A	3soaA-2zfuA: undetectable	3soaA-2zfuA: 19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C9W_A_VGHA1158_1 (7,8-DIHYDRO-8-OXOGUA NINE TRIPHOSPHATASE)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 375 PHE A 403 VAL A 407 PHE A 397 GLN A 449	None	1.32A	4c9wA-2zfuA: undetectable	4c9wA-2zfuA: 23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DCM_A_SAMA401_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE G)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 11	PHE A 284 ASP A 314 GLY A 316 GLY A 318 ASP A 334	SAH A 900 (-3.7A) SAH A 900 ( 4.6A) SAH A 900 (-3.5A) SAH A 900 ( 3.7A) SAH A 900 (-2.7A)	0.68A	4dcmA-2zfuA: 12.1	4dcmA-2zfuA: 21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F84_A_SAMA501_0 (GERANYL DIPHOSPHATE 2-C-METHYLTRANSFERAS E)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 12	GLY A 316 GLY A 318 LEU A 335 MET A 347 SER A 365	SAH A 900 (-3.5A) SAH A 900 ( 3.7A) SAH A 900 (-4.2A) SAH A 900 (-3.6A) SAH A 900 (-4.7A)	0.46A	4f84A-2zfuA: 12.7	4f84A-2zfuA: 23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KRH_A_SAMA900_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE 2)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 12	TYR A 280 GLY A 316 GLY A 318 LEU A 335 ASP A 346	None SAH A 900 (-3.5A) SAH A 900 ( 3.7A) SAH A 900 (-4.2A) SAH A 900 (-3.6A)	0.91A	4krhA-2zfuA: 11.1	4krhA-2zfuA: 20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PGH_A_SAMA401_0 (CAFFEIC ACID O-METHYLTRANSFERASE)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 11	GLY A 316 ASP A 334 LEU A 335 ASP A 346 MET A 347	SAH A 900 (-3.5A) SAH A 900 (-2.7A) SAH A 900 (-4.2A) SAH A 900 (-3.6A) SAH A 900 (-3.6A)	0.52A	4pghA-2zfuA: 7.5	4pghA-2zfuA: 21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PGH_A_SAMA401_0 (CAFFEIC ACID O-METHYLTRANSFERASE)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 11	GLY A 318 ASP A 334 LEU A 335 ASP A 346 MET A 347	SAH A 900 ( 3.7A) SAH A 900 (-2.7A) SAH A 900 (-4.2A) SAH A 900 (-3.6A) SAH A 900 (-3.6A)	0.92A	4pghA-2zfuA: 7.5	4pghA-2zfuA: 21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PGH_B_SAMB401_0 (CAFFEIC ACID O-METHYLTRANSFERASE)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	6 / 12	ASP A 314 GLY A 316 ASP A 334 LEU A 335 ASP A 346 MET A 347	SAH A 900 ( 4.6A) SAH A 900 (-3.5A) SAH A 900 (-2.7A) SAH A 900 (-4.2A) SAH A 900 (-3.6A) SAH A 900 (-3.6A)	0.65A	4pghB-2zfuA: 10.5	4pghB-2zfuA: 21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PGH_C_SAMC401_0 (CAFFEIC ACID O-METHYLTRANSFERASE)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 11	GLY A 316 ASP A 334 LEU A 335 ASP A 346 MET A 347	SAH A 900 (-3.5A) SAH A 900 (-2.7A) SAH A 900 (-4.2A) SAH A 900 (-3.6A) SAH A 900 (-3.6A)	0.58A	4pghC-2zfuA: 11.2	4pghC-2zfuA: 21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XEY_A_1N1A601_2 (TYROSINE-PROTEIN KINASE ABL1)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	3 / 3	MET A 367 ASP A 334 PHE A 333	SAH A 900 ( 3.7A) SAH A 900 (-2.7A) None	0.72A	4xeyA-2zfuA: undetectable	4xeyA-2zfuA: 19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XEY_B_1N1B601_2 (TYROSINE-PROTEIN KINASE ABL1)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	3 / 3	MET A 367 ASP A 334 PHE A 333	SAH A 900 ( 3.7A) SAH A 900 (-2.7A) None	0.69A	4xeyB-2zfuA: 1.1	4xeyB-2zfuA: 19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DSG_B_0HKB1201_1 (MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYS IN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 12	SER A 286 TRP A 291 LEU A 364 TYR A 280 ASN A 255	None None SAH A 900 (-4.9A) None None	1.35A	5dsgB-2zfuA: undetectable	5dsgB-2zfuA: 18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E72_A_SAMA400_1 (N2, N2-DIMETHYLGUANOSINE TRNA METHYLTRANSFERASE)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	4 / 4	ASP A 314 GLY A 318 ASP A 334 ASP A 346	SAH A 900 ( 4.6A) SAH A 900 ( 3.7A) SAH A 900 (-2.7A) SAH A 900 (-3.6A)	0.53A	5e72A-2zfuA: 10.9	5e72A-2zfuA: 23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JQ7_B_T0RB705_1 (ENVELOPE GLYCOPROTEIN 1,ENVELOPE GLYCOPROTEIN 1,ENVELOPE GLYCOPROTEIN 1 ENVELOPE GLYCOPROTEIN 2)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	4 / 7	VAL A 390 LEU A 388 LEU A 366 LEU A 448	None	0.69A	5jq7A-2zfuA: undetectable	5jq7A-2zfuA: 21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O96_A_SAMA501_0 (RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 11	LEU A 388 GLU A 355 GLY A 385 LEU A 375 ALA A 378	None	1.07A	5o96A-2zfuA: undetectable 5o96B-2zfuA: undetectable	5o96A-2zfuA: 24.00 5o96B-2zfuA: 24.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VEU_A_RITA602_2 (CYTOCHROME P450 3A5)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	3 / 3	ARG A 298 PHE A 362 LEU A 322	None	0.70A	5veuA-2zfuA: undetectable	5veuA-2zfuA: 19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WAU_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	4 / 5	PHE A 374 PHE A 362 LEU A 388 PHE A 412	SAH A 900 (-4.3A) None None None	1.34A	5wauC-2zfuA: undetectable 5wauJ-2zfuA: undetectable	5wauC-2zfuA: 19.85 5wauJ-2zfuA: 16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_C_CHDC308_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	4 / 5	PHE A 374 PHE A 362 LEU A 388 PHE A 412	SAH A 900 (-4.3A) None None None	1.34A	5xdqC-2zfuA: undetectable 5xdqJ-2zfuA: undetectable	5xdqC-2zfuA: 19.85 5xdqJ-2zfuA: 16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6I5Z_D_SAMD401_0 (O-METHYLTRANSFERASE 1)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	6 / 11	GLY A 316 GLY A 318 ASP A 334 LEU A 335 ASP A 346 MET A 347	SAH A 900 (-3.5A) SAH A 900 ( 3.7A) SAH A 900 (-2.7A) SAH A 900 (-4.2A) SAH A 900 (-3.6A) SAH A 900 (-3.6A)	0.50A	6i5zD-2zfuA: 10.1	6i5zD-2zfuA: 21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NJ9_K_SAMK500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC)	2zfu	CEREBRAL PROTEIN 1 (Homo sapiens)	5 / 12	ASP A 314 GLY A 316 GLY A 318 ALA A 336 ASP A 346	SAH A 900 ( 4.6A) SAH A 900 (-3.5A) SAH A 900 ( 3.7A) None SAH A 900 (-3.6A)	1.05A	6nj9K-2zfuA: 3.1	6nj9K-2zfuA: 20.05

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1MZ9_A_VDYA1002_4","CARTILAGE OLIGOMERIC MATRIX PROTEIN;CARTILAGE OLIGOMERIC MATRIX PROTEIN","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",4,"VAL A 342;CYH A 332;ALA A 323;CYH A 320","None","1.12A","1mz9D-2zfuA:undetectable","1mz9D-2zfuA:11.43"],["1X1A_A_SAMA4264_0","CRTF-RELATED PROTEIN","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"GLY A 316;GLY A 318;LEU A 335;ASP A 346;CYH A 363","SAH A 900 (-3.5A);SAH A 900 ( 3.7A);SAH A 900 (-4.2A);SAH A 900 (-3.6A);SAH A 900 (-3.4A)","0.93A","1x1aA-2zfuA:12.9","1x1aA-2zfuA:19.38"],["2AVV_E_MK1E902_4","POL POLYPROTEIN","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",3,"ARG A 298;VAL A 415;GLY A 386","None","0.66A","2avvE-2zfuA:undetectable","2avvE-2zfuA:19.90"],["2C2B_E_SAME500_0","THREONINE SYNTHASE 1, CHLOROPLASTIC","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"SER A 263;GLY A 261;SER A 260;LEU A 366;ASP A 346","SAH A 900 (-4.2A);None;None;None;SAH A 900 (-3.6A)","0.99A","2c2bE-2zfuA:0.7;2c2bF-2zfuA:0.5","2c2bE-2zfuA:18.84;2c2bF-2zfuA:18.84"],["2Y69_C_CHDC1265_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",4,"PHE A 374;PHE A 362;LEU A 388;PHE A 412","SAH A 900 (-4.3A);None;None;None","1.36A","2y69C-2zfuA:undetectable;2y69J-2zfuA:undetectable","2y69C-2zfuA:19.85;2y69J-2zfuA:17.62"],["3ABM_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",4,"PHE A 374;PHE A 362;LEU A 388;PHE A 412","SAH A 900 (-4.3A);None;None;None","1.36A","3abmP-2zfuA:undetectable;3abmW-2zfuA:undetectable","3abmP-2zfuA:19.85;3abmW-2zfuA:16.32"],["3AG3_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",4,"PHE A 374;PHE A 362;LEU A 388;PHE A 412","SAH A 900 (-4.3A);None;None;None","1.33A","3ag3C-2zfuA:undetectable;3ag3J-2zfuA:undetectable","3ag3C-2zfuA:19.85;3ag3J-2zfuA:16.32"],["3G2O_B_SAMB600_0","PCZA361.24","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"GLY A 318;LEU A 322;LEU A 335;ASP A 346;MET A 347","SAH A 900 ( 3.7A);None;SAH A 900 (-4.2A);SAH A 900 (-3.6A);SAH A 900 (-3.6A)","0.75A","3g2oB-2zfuA:12.4","3g2oB-2zfuA:23.53"],["3G2O_B_SAMB600_0","PCZA361.24","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"GLY A 318;LEU A 335;ASP A 346;MET A 347;SER A 365","SAH A 900 ( 3.7A);SAH A 900 (-4.2A);SAH A 900 (-3.6A);SAH A 900 (-3.6A);SAH A 900 (-4.7A)","0.95A","3g2oB-2zfuA:12.4","3g2oB-2zfuA:23.53"],["3I5U_B_SAMB401_1","O-METHYLTRANSFERASE","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",3,"ASP A 334;PHE A 270;SER A 263","SAH A 900 (-2.7A);None;SAH A 900 (-4.2A)","0.79A","3i5uB-2zfuA:11.6","3i5uB-2zfuA:22.94"],["3OU7_C_SAMC300_1","SAM-DEPENDENT METHYLTRANSFERASE","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",3,"GLY A 318;ASP A 334;ASP A 346","SAH A 900 ( 3.7A);SAH A 900 (-2.7A);SAH A 900 (-3.6A)","0.36A","3ou7C-2zfuA:10.2","3ou7C-2zfuA:24.42"],["3PFG_A_SAMA264_0","N-METHYLTRANSFERASE","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"TYR A 280;GLY A 318;LEU A 335;ASP A 346;MET A 347","None;SAH A 900 ( 3.7A);SAH A 900 (-4.2A);SAH A 900 (-3.6A);SAH A 900 (-3.6A)","0.98A","3pfgA-2zfuA:11.6","3pfgA-2zfuA:23.74"],["3R9V_B_DXCB1_0","INVASIN IPAD","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",4,"ILE A 326;LEU A 322;VAL A 381;SER A 356","None","0.97A","3r9vA-2zfuA:undetectable;3r9vB-2zfuA:undetectable","3r9vA-2zfuA:22.66;3r9vB-2zfuA:22.66"],["3SOA_A_DB8A445_1","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II SUBUNIT ALPHA WITH A BETA 7 LINKER","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",4,"LEU A 352;VAL A 350;PHE A 315;VAL A 357","None","1.12A","3soaA-2zfuA:undetectable","3soaA-2zfuA:19.24"],["4C9W_A_VGHA1158_1","7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"LEU A 375;PHE A 403;VAL A 407;PHE A 397;GLN A 449","None","1.32A","4c9wA-2zfuA:undetectable","4c9wA-2zfuA:23.42"],["4DCM_A_SAMA401_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE G","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"PHE A 284;ASP A 314;GLY A 316;GLY A 318;ASP A 334","SAH A 900 (-3.7A);SAH A 900 ( 4.6A);SAH A 900 (-3.5A);SAH A 900 ( 3.7A);SAH A 900 (-2.7A)","0.68A","4dcmA-2zfuA:12.1","4dcmA-2zfuA:21.37"],["4F84_A_SAMA501_0","GERANYL DIPHOSPHATE 2-C-METHYLTRANSFERASE","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"GLY A 316;GLY A 318;LEU A 335;MET A 347;SER A 365","SAH A 900 (-3.5A);SAH A 900 ( 3.7A);SAH A 900 (-4.2A);SAH A 900 (-3.6A);SAH A 900 (-4.7A)","0.46A","4f84A-2zfuA:12.7","4f84A-2zfuA:23.36"],["4KRH_A_SAMA900_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE 2","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"TYR A 280;GLY A 316;GLY A 318;LEU A 335;ASP A 346","None;SAH A 900 (-3.5A);SAH A 900 ( 3.7A);SAH A 900 (-4.2A);SAH A 900 (-3.6A)","0.91A","4krhA-2zfuA:11.1","4krhA-2zfuA:20.32"],["4PGH_A_SAMA401_0","CAFFEIC ACID O-METHYLTRANSFERASE","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"GLY A 316;ASP A 334;LEU A 335;ASP A 346;MET A 347","SAH A 900 (-3.5A);SAH A 900 (-2.7A);SAH A 900 (-4.2A);SAH A 900 (-3.6A);SAH A 900 (-3.6A)","0.52A","4pghA-2zfuA:7.5","4pghA-2zfuA:21.22"],["4PGH_A_SAMA401_0","CAFFEIC ACID O-METHYLTRANSFERASE","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"GLY A 318;ASP A 334;LEU A 335;ASP A 346;MET A 347","SAH A 900 ( 3.7A);SAH A 900 (-2.7A);SAH A 900 (-4.2A);SAH A 900 (-3.6A);SAH A 900 (-3.6A)","0.92A","4pghA-2zfuA:7.5","4pghA-2zfuA:21.22"],["4PGH_B_SAMB401_0","CAFFEIC ACID O-METHYLTRANSFERASE","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",6,"ASP A 314;GLY A 316;ASP A 334;LEU A 335;ASP A 346;MET A 347","SAH A 900 ( 4.6A);SAH A 900 (-3.5A);SAH A 900 (-2.7A);SAH A 900 (-4.2A);SAH A 900 (-3.6A);SAH A 900 (-3.6A)","0.65A","4pghB-2zfuA:10.5","4pghB-2zfuA:21.22"],["4PGH_C_SAMC401_0","CAFFEIC ACID O-METHYLTRANSFERASE","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"GLY A 316;ASP A 334;LEU A 335;ASP A 346;MET A 347","SAH A 900 (-3.5A);SAH A 900 (-2.7A);SAH A 900 (-4.2A);SAH A 900 (-3.6A);SAH A 900 (-3.6A)","0.58A","4pghC-2zfuA:11.2","4pghC-2zfuA:21.22"],["4XEY_A_1N1A601_2","TYROSINE-PROTEIN KINASE ABL1","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",3,"MET A 367;ASP A 334;PHE A 333","SAH A 900 ( 3.7A);SAH A 900 (-2.7A);None","0.72A","4xeyA-2zfuA:undetectable","4xeyA-2zfuA:19.02"],["4XEY_B_1N1B601_2","TYROSINE-PROTEIN KINASE ABL1","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",3,"MET A 367;ASP A 334;PHE A 333","SAH A 900 ( 3.7A);SAH A 900 (-2.7A);None","0.69A","4xeyB-2zfuA:1.1","4xeyB-2zfuA:19.02"],["5DSG_B_0HKB1201_1","MUSCARINIC ACETYLCHOLINE RECEPTOR M4,ENDOLYSIN,ENDOLYSIN,MUSCARINIC ACETYLCHOLINE RECEPTOR M4","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"SER A 286;TRP A 291;LEU A 364;TYR A 280;ASN A 255","None;None;SAH A 900 (-4.9A);None;None","1.35A","5dsgB-2zfuA:undetectable","5dsgB-2zfuA:18.84"],["5E72_A_SAMA400_1","N2, N2-DIMETHYLGUANOSINE TRNA METHYLTRANSFERASE","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",4,"ASP A 314;GLY A 318;ASP A 334;ASP A 346","SAH A 900 ( 4.6A);SAH A 900 ( 3.7A);SAH A 900 (-2.7A);SAH A 900 (-3.6A)","0.53A","5e72A-2zfuA:10.9","5e72A-2zfuA:23.19"],["5JQ7_B_T0RB705_1","ENVELOPE GLYCOPROTEIN 1,ENVELOPE GLYCOPROTEIN 1,ENVELOPE GLYCOPROTEIN 1;ENVELOPE GLYCOPROTEIN 2","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",4,"VAL A 390;LEU A 388;LEU A 366;LEU A 448","None","0.69A","5jq7A-2zfuA:undetectable","5jq7A-2zfuA:21.98"],["5O96_A_SAMA501_0","RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"LEU A 388;GLU A 355;GLY A 385;LEU A 375;ALA A 378","None","1.07A","5o96A-2zfuA:undetectable;5o96B-2zfuA:undetectable","5o96A-2zfuA:24.00;5o96B-2zfuA:24.00"],["5VEU_A_RITA602_2","CYTOCHROME P450 3A5","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",3,"ARG A 298;PHE A 362;LEU A 322","None","0.70A","5veuA-2zfuA:undetectable","5veuA-2zfuA:19.26"],["5WAU_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",4,"PHE A 374;PHE A 362;LEU A 388;PHE A 412","SAH A 900 (-4.3A);None;None;None","1.34A","5wauC-2zfuA:undetectable;5wauJ-2zfuA:undetectable","5wauC-2zfuA:19.85;5wauJ-2zfuA:16.32"],["5XDQ_C_CHDC308_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",4,"PHE A 374;PHE A 362;LEU A 388;PHE A 412","SAH A 900 (-4.3A);None;None;None","1.34A","5xdqC-2zfuA:undetectable;5xdqJ-2zfuA:undetectable","5xdqC-2zfuA:19.85;5xdqJ-2zfuA:16.32"],["6I5Z_D_SAMD401_0","O-METHYLTRANSFERASE 1","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",6,"GLY A 316;GLY A 318;ASP A 334;LEU A 335;ASP A 346;MET A 347","SAH A 900 (-3.5A);SAH A 900 ( 3.7A);SAH A 900 (-2.7A);SAH A 900 (-4.2A);SAH A 900 (-3.6A);SAH A 900 (-3.6A)","0.50A","6i5zD-2zfuA:10.1","6i5zD-2zfuA:21.55"],["6NJ9_K_SAMK500_0","HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC","2zfu","CEREBRAL PROTEIN 1","Homo sapiens",5,"ASP A 314;GLY A 316;GLY A 318;ALA A 336;ASP A 346","SAH A 900 ( 4.6A);SAH A 900 (-3.5A);SAH A 900 ( 3.7A);None;SAH A 900 (-3.6A)","1.05A","6nj9K-2zfuA:3.1","6nj9K-2zfuA:20.05"]]